Question 1

What is BlossomHill Therapeutics?

Accepted Answer

BlossomHill Therapeutics is a Entity.

Question 2

How often does BlossomHill Therapeutics appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 33 articles.

Question 3

When was BlossomHill Therapeutics first tracked by Ergen?

Accepted Answer

First tracked on Jul 06, 2026.

Question 4

When was BlossomHill Therapeutics last mentioned in news?

Accepted Answer

Last active on Aug 07, 2026.

Question 5

What is BlossomHill Therapeutics's current news sentiment?

Accepted Answer

Aggregate sentiment score: 55 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is BlossomHill Therapeutics in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving BlossomHill Therapeutics?

Accepted Answer

BlossomHill Therapeutics $150M IPO Pricing (Aug 07, 2026, 8 articles).

Question 8

How did the "BlossomHill Therapeutics $150M IPO Pricing" event impact BlossomHill Therapeutics?

Accepted Answer

BlossomHill Therapeutics is the issuer of the IPO, raising $150 million to fund its clinical programs. The successful offering enhances its financial position and validates its pipeline, positively impacting its market sentiment.

Question 9

How did the "Scribe Therapeutics upsized IPO closes" event impact BlossomHill Therapeutics?

Accepted Answer

BlossomHill Therapeutics is another biotech planning an IPO, likely to benefit from market conditions.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.